Neurocutaneous melanocytosis (Q93770): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Melanocitose neurocutânea (NCM) é um transtorno neurológico congênito raro caracterizado por agregados anormais de nevos melanocíticos no sistema nervoso central (melanocitose leptomeníngea) associada a nevos melanocíticos congênitos grandes ou gigantes (CMN; ver este termo). A NCM pode ser assintomática ou apresentar comprometimento neurológico variavelmente grave e progressivo, às vezes resultando em morte. A prevalência é estimada em 1/50.000-1/200.000. A incidência de NCM sintomática parece ser de aproximadamente um terço a metade destes casos. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Neurocutaneous melanocytosis (NCM) is a rare congenital neurological disorder characterised by abnormal aggregations of naevomelanocytes within the central nervous system (leptomeningeal melanocytosis) associated with large or giant congenital melanocytic naevi (CMN; see this term). NCM can be asymptomatic or present as variably severe and progressive neurological impairment, sometimes resulting in death. Prevalence is estimated at 1/50,000-1/200,000. The incidence of symptomatic NCM appears to be approximately a third to a half of these. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/403221860 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_403221860 | |||||||||||||||
| Property / CURIE: CID11:ID_403221860 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_403221860 | |||||||||||||||
| Property / Canary Token: dki-india-ID_403221860 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 08:52, 16 August 2026
Neurocutaneous melanocytosis (NCM) is a rare congenital neurological disorder characterised by abnormal aggregations of naevomelanocytes within the central nervous system (leptomeningeal melanocytosis) associated with large or giant congenital melanocytic naevi (CMN; see this term). NCM can be asymptomatic or present as variably severe and progressive neurological impairment, sometimes resulting in death. Prevalence is estimated at 1/50,000-1/200,000. The incidence of symptomatic NCM appears to be approximately a third to a half of these.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_403221860 |
||
| English | Neurocutaneous melanocytosis |
Neurocutaneous melanocytosis (NCM) is a rare congenital neurological disorder characterised by abnormal aggregations of naevomelanocytes within the central nervous system (leptomeningeal melanocytosis) associated with large or giant congenital melanocytic naevi (CMN; see this term). NCM can be asymptomatic or present as variably severe and progressive neurological impairment, sometimes resulting in death. Prevalence is estimated at 1/50,000-1/200,000. The incidence of symptomatic NCM appears to be approximately a third to a half of these. |
Statements
CID11:ID_403221860
0 references
dki-india-ID_403221860
0 references
Concluído
0 references
15 August 2026
0 references
